The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 26, 2024

Filed:

May. 01, 2020
Applicant:

Genevant Sciences Gmbh, Basel, CH;

Inventors:

Sean D. Monahan, Lake Forest Park, WA (US);

Michael S. Declue, Seattle, WA (US);

Pierrot Harvie, Seattle, WA (US);

Russell N. Johnson, Seattle, WA (US);

Amber E. Paschal, Redmond, WA (US);

Mary G. Prieve, Lake Forest Park, WA (US);

Debashish Roy, Seattle, WA (US);

Charbel Diab, Tustin, CA (US);

Michael E. Houston, Jr., Kirkland, WA (US);

Anna Galperin, Seattle, WA (US);

Maher Qabar, Sammamish, WA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/64 (2017.01); A01K 67/027 (2006.01); A61K 38/08 (2019.01); A61K 38/44 (2006.01); A61K 47/54 (2017.01); A61K 47/58 (2017.01); A61K 48/00 (2006.01); C08F 293/00 (2006.01); C12N 15/113 (2010.01); C12N 15/87 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6455 (2017.08); A01K 67/027 (2013.01); A61K 38/08 (2013.01); A61K 38/44 (2013.01); A61K 47/549 (2017.08); A61K 47/58 (2017.08); A61K 48/0041 (2013.01); C08F 293/005 (2013.01); C12N 15/113 (2013.01); C12N 15/87 (2013.01); A01K 2207/05 (2013.01); C12N 2310/14 (2013.01); C12N 2310/351 (2013.01); C12N 2320/32 (2013.01); C12Y 113/12007 (2013.01);
Abstract

Described herein are block copolymers, and methods of making and utilizing such copolymers. The described block copolymers are disruptive of a cellular membrane, including an extracellular membrane, an intracellular membrane, a vesicle, an organelle, an endosome, a liposome, or a red blood cell. Preferably, in certain instances, the block copolymer disrupts the membrane and enters the intracellular environment. In specific examples, the block copolymer is endosomolytic and capable of delivering an oligonucleotide (e.g., an mRNA) to a cell. Compositions comprising a block copolymer and an oligonucleotide (e.g., an mRNA) are also disclosed.


Find Patent Forward Citations

Loading…